If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,068.00    14.50 (1.38%)
Bid:
1,066.00
Ask:
1,067.00
Spread: 1.00 (0.094%)
Market Cap: £3.43b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Director/PDMR Shareholding

13 May 2013 14:51

RNS Number : 5876E
Persimmon PLC
13 May 2013
 

13 MAY 2013

Persimmon PLC (the 'Company')

 

 

RETURN OF CASH TO SHAREHOLDERS UNDER B/C SHARE SCHEME

NOTIFICATION OF TRANSACTIONS OF DIRECTORS AND CONNECTED PERSONS

 

 

The Company was notified on 10 May 2013 by its Directors that on 6 May 2013 they and their connected persons acquired interests in B Shares and C Shares under the Return of Cash as follows:-

 

Name of Director/ Connected Person

No of B Shares of 75 pence each

Percentage of issued B Shares

No of C Shares of 0.0001 pence each

Percentage of issued C Shares

Jeff Fairburn

157,360

0.15

8,445

Jayne Fairburn

-

-

6,706

Mike Killoran

638,526

0.62

-

-

Jacqueline Flanigan*

20,817

0.02

-

-

Nigel Greenaway

-

-

30,137

0.01

Nicholas Wrigley

26,000

0.03

Suzanne Pennycook

-

-

643

Jonathan Davie

10,000

-

-

Mark Preston

500

-

-

Marion Sears

5,648

175

*Wife of Mike Killoran

 

Mike Killoran and Jacqueline Flanigan also have a non-beneficial interest in 64,022 C Shares (being 0.3% of the issued C Shares).

 

It is expected that each B Share will be redeemed by the Company for 75 pence on 28 June 2013 and that the proceeds of the redemption will be sent to Shareholders or CREST accounts will be credited, by 28 June 2013. Each such B Share will be cancelled on redemption.

 

A single dividend of 75 pence will become payable on each C Share on 28 June 2013. Once the C Share Dividend has been paid, each C Share will be reclassified as a Deferred Share which will carry extremely limited rights and will have negligible value. The Company expects to purchase the Deferred Shares for an aggregate consideration of one penny and then cancel the Deferred Shares in July 2013. Shareholders will not be entitled to have any part of the one penny aggregate consideration paid to them.

 

Capitalised terms in this announcement shall have the same meaning ascribed to them as in the Circular published by the Company on 18 March 2013 in relation to the proposed Return of Cash. The circular is available on the Company's website at www.corporate.persimmonhomes.com/investor/shareholder/gminfo/2013.aspx

 

As at 13 May 2013 the issued share capital of the Company was 303,842,439 ordinary shares of 10 pence each, 102,245,506 B Shares of 75 pence each and 201,590,249 C Shares of 0.0001 pence each.

 

 

G N Francis

Group Company Secretary

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEADSDFLNDEFF
Date   Source Headline
1st May 20252:20 pmRNSResult of AGM
1st May 20252:02 pmRNSTotal Voting Rights
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.